×
Events & Presentations · Upcoming Events · Featured Presentation · Past Events · Investor Contact · Investor Email Alerts · Email Alert Sign Up Confirmation ...
Aeglea BioTherapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Program Updates Read More ... Investor Contact. investors@aeglea.
Spyre Therapeutics is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining best-in-class ...
People also ask
... Investor Relations, telephone number (512) 942-2935. Any stockholders who share the same address and currently receive multiple copies of Aeglea's annual report ...
Nov 28, 2023 · (NASDAQ: AGLE) (the "Company" or "Spyre"), a development-stage biotechnology company, today announced its name change to Spyre Therapeutics, Inc ...
Nov 9, 2023 · 9, 2023 /PRNewswire/ -- Aeglea BioTherapeutics, Inc. ("Aeglea" or the "Company") (NASDAQ:AGLE), a biotechnology company advancing a pipeline of ...
Rating (1,975)
Aeglea Biotherapeutics Inc (AGLE) will release its next earnings report on Mar 13, 2024 ... investors and does not represent returns that any investor actually ...
Discover Eagle IR's exceptional services, including corporate access, market intelligence, and tailored resources for both corporate & investment ...
AGLE@investorrelations.com. Investor Contact: Joey Perrone. Senior Director, Finance & Investor Relations. Aeglea BioTherapeutics. investors@aegleabio.com.
Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations